PRAME antibody

Cat.#: 114165

Size:

Special Price 239.0 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    PRAME antibody
  • Documents
  • Description
    PRAME Rabbit Polyclonal antibody. Positive IP detected in A549 cells. Positive WB detected in A549 cells, HepG2 cells. Observed molecular weight by Western-blot: 58 kDa
  • Tested applications
    ELISA, WB, IP
  • Species reactivity
    Human; other species not tested.
  • Alternative names
    MAPE antibody; OIP 4 antibody; OIP4 antibody; Opa interacting protein 4 antibody; PRAME antibody
  • Isotype
    Rabbit IgG
  • Preparation
    This antibody was obtained by immunization of PRAME recombinant protein (Accession Number: NM_001291716). Purification method: Antigen affinity purified.
  • Clonality
    Polyclonal
  • Formulation
    PBS with 0.1% sodium azide and 50% glycerol pH 7.3.
  • Storage instructions
    Store at -20℃. DO NOT ALIQUOT
  • Applications

    Recommended Dilution:

    WB: 1:200-1:1000

    IP: 1:200-1:1000

  • Validations

    A549 cells were subjected to SDS PAGE followed by western blot with Catalog No:114165(PRAME Antibody) at dilution of 1:300

    A549 cells were subjected to SDS PAGE followed by western blot with Catalog No:114165(PRAME Antibody) at dilution of 1:300

    IP Result of anti-PRAME (IP:Catalog No:114165, 3ug; Detection:Catalog No:114165 1:300) with A549 cells lysate 2400ug.

    IP Result of anti-PRAME (IP:Catalog No:114165, 3ug; Detection:Catalog No:114165 1:300) with A549 cells lysate 2400ug.

  • Background
    The PRAME (preferentially expressed antigen of melanoma) gene was previously shown to be overexpressed in ovarian/primary peritoneal serous carcinoma compared with malignant mesothelioma using gene expression arrays. It is considered a melanocyte differentiation antigen which is overexpressed in both solid and hematologic tumors. In normal tissue, a very low level of PRAME expression is found in normal testis, adrenals, ovary and endometrium. A high level of PRAME expression has been reported for several solid tumors, including ovarian cancer, breast cancer, lung cancer and melanomas, medulloblastoma, sarcomas, head and neck cancers, neuroblastoma, renal cancer, and Wilms’ tumor. As a nuclear transcriptional repressor protein, PRAME binds to retinoic acid receptor a, thereby inhibiting retinoic acid induced differentiation, growth arrest, and apoptosis.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"